InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 184063

Wednesday, 08/16/2017 12:26:46 AM

Wednesday, August 16, 2017 12:26:46 AM

Post# of 345981

Must See Presentation..Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL : .



Ok we know Peregrine has already proven PS Targeting reduces MDSCs by at least 40% and here is another late comer talking about MDSCs .....listen to the 6min - 7min mark...

Seems like MDSCs are important to reduce!! Ronin group, you hear this ???


Published Online: Tuesday, Aug 15, 2017
http://www.onclive.com/peer-exchange/strategies-in-kidney-cancer/emerging-immunotherapy-combinations-in-kidney-cancer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News